1. Home
  2. Browse
  3. Cardiology
  4. Resources
  5. Drug-Induced Cardiovascular Disease

Drug-Induced Cardiovascular Disease

136 - 150 of 199 Results
Sort Results:
Guideline: ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents (2011) December 2011
Guideline: Implementing the Key Action Statements: An Algorithm and Explanation for Process of Care for the Evaluation, Diagnosis, Treatment, and Monitoring of ADHD in Children and Adolescents (2011) December 2011
Guideline: Diagnosis and Management of Attention Deficit Hyperactivity Disorder in Primary Care for School-Age Children and Adolescents (2010) December 2011
Article: how OTC Fastin is different from Rx Fastin December 2011
Article: You'll continue to see shortages of "stimulant" ADHD drugs (Adderall, Ritalin, etc) December 2011
Article: Ondansetron (Zofran, etc) will join the list of drugs getting stronger warnings about "QT prolongation" December 2011
Article: new combo drug, Juvisync (JU-vih-sink), for treating diabetes November 2011
Commentary: Diabetes Meds and Cardiovascular Risk November 2011
Commentary: QT Prolongation, Torsades de Pointes, & Medication Safety September 2011
Article: stronger warnings about Seroquel (quetiapine) and "QT prolongation" heart problems September 2011
Commentary: New Vardenafil Formulation: Staxyn August 2011
Chart: Phosphodiesterase 5 (PDE5) Inhibitor Interactions August 2011
Guideline: Treating Tobacco Use and Dependence (2008 Update) August 2011
Guideline: Use of Sildenafil (Viagra) in Patients With Cardiovascular Disease (1999) August 2011
Commentary: Chantix (Varenicline): New Safety Information and Instructions For Use August 2011